Intellectual Property Notes

Challenges for the Consumer sector - Transformative Technology

Patent and Pharma Update - April 2019

The European Parliament votes in the EU Copyright Directive including controversial Articles 11 and 13

The Court of Justice of the European Union holds that Supplementary Protection Certificates cannot be obtained for new formulations of previously approved active ingredients in Abraxis (Case C-443/17)

Misleading brand name ‘Glen Buchenbach’ infringes the registered geographical indication 'Scotch Whisky'

Political agreement reached on controversial EU Digital Copyright Directive: A fair and balanced result?

Following a turbulent course of lengthy negotiations and delays, political agreement was finally reached by the European Commission, European Parliament …

Herbert Smith Freehills' global Trade Marks Practice lauded a 'formidable force' in WTR 1000 rankings

JAPAN-EU FREE TRADE AGREEMENT NOW IN FORCE

The Japan-EU Economic Partnership Agreement, the largest free-trade agreement between Japan and the EU (aka Japan-EU Free Trade Agreement or JEFTA) …

Preparations for the UPC continue despite an "unpredictable environment"

The UPC Preparatory Committee has issued a “Status of the Unified Patent Court Project” statement and review of 2018, confirming that there …

Advocate General proposes literal interpretation of Article 3(d) SPC Regulation in Abraxis (C-443/17)

The Advocate General of the CJEU proposed a narrow interpretation of Article    3(d) in the Opinion given yesterday in Abraxis …

French court upholds validity of MSD's SPC protecting ezetimibe and simvastatin in combination

A French Court has upheld the validity of a Supplementary Protection Certificate ("SPC") protecting the ezetimibe+simvastatin combination under Article …

France adopts a confidentiality regime for the trade secrets relied upon in (patent) litigation

As part of the French Law on the Protection of Trade Secrets dated 31 July 2018, French lawmakers have finally adopted a long-awaited array of …